Francis Goudaliez

This inventor holds 19 USPTO granted patents and 1 published patent application, plus 5 CIPO patents and 10 EPO patents, primarily in Biological Fluid Handling. Top assignees: Macopharma, Maco Pharma S.a.. Active years: 2005-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francis Goudaliez. Retrieved from https://idiyas.com/inventor/francis-goudaliez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 1)

% Patents Active = 31.6

CIPO Patents = 5

EPO Patents = 10 (Patent Applications = 5)

Average Co-Inventor Count = 2.6

ph-index = 8

Forward Citations = 226(Granted Patents)

Location History:

Faches-Tumesnil, FR (2009)
Faches-Thunesnil, FR (2011)
Faches-Thumesnil, FR (2005 - 2023)

Company Filing History:

Years Active: 2005-2025

Loading Chart...

Areas of Expertise:

Sterilisation

Platelet Lysate

Pathogen Inactivation

Biological Fluid

Irradiation Apparatus

Collection Bag

Filtering Unit

Aseptic Transfer

Fluid Communication

Sampling Receptacles

Automatic Handling

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12370218 - Method for sterilising a platelet lysate (2025-07-29),

2. 11690875 - Method for sterilising a platelet lysate (2023-07-04),

3. 10946046 - Method for sterilising a platelet lysate (2021-03-16),

4. 10058646 - Blood bag system and process for the inactivation of pathogens in platelet concentrates by use of the blood bag system (2018-08-28),

5. 9320817 - Irradiation apparatus for inactivating pathogens and/or leukocytes in a biological fluid and process (2016-04-26),

6. 8986237 - Methods of making and using filtering unit for a virucide substance (2015-03-24),

7. 8778263 - Irradiation apparatus for inactivating pathogens and/or leukocytes in a biological fluid and process (2014-07-15),

8. 8388597 - Bag system with device for associating sampling receptacles (2013-03-05),

9. 7879000 - Method, system and machine for collecting a biological fluid to which a selected ratio of solution is added (2011-02-01),

10. 7766854 - Device and method for irreversible closure of fluid communication in a container system (2010-08-03),

11. 7621298 - Recipient equipped with an aseptic transfer system (2009-11-24),

12. 7618407 - Bag system with device for associating sampling receptacles (2009-11-17),

13. 7503901 - Collection bag system with preformed loop (2009-03-17),

14. 7427278 - Extraction device with tubes having different cross-sections (2008-09-23),

15. 7384416 - Device and method for irreversible closure of fluid communication in a container system (2008-06-10),

Title: **The Innovations of Francis Goudaliez: A Leader in Platelet Lysate Sterilization**

Introduction

Francis Goudaliez, based in Faches-Thumesnil, France, is an accomplished inventor with a noteworthy portfolio of 18 patents. His groundbreaking work focuses primarily on the field of biomedical innovations, specifically in the sterilization of platelet lysates which are critical in therapeutic applications.

Latest Patents

Among his significant contributions, Goudaliez's latest patents include a method for sterilizing a platelet lysate in the liquid state. This method involves utilizing endogenous growth factors such as TGF-beta 1, EGF, PDGF-AB, IGF-1, VEGF, and bFGF. The innovative process begins by freezing the liquid platelet lysate to create a frozen product, which is then irradiated with ionizing radiation. This carefully calibrated irradiation preserves at least 80% of the concentration of one or more of the crucial growth factors, enhancing the efficacy and safety of the platelet lysate in medical applications.

Career Highlights

Throughout his career, Francis Goudaliez has made substantial impacts in the biomedical space, particularly concerning the development of methodologies that improve the handling and application of platelet lysates. His inventions have not only advanced medical treatment options but have contributed to the overall understanding of growth factor dynamics in therapeutic environments.

Collaborations

Goudaliez has worked with esteemed companies such as Macopharma and Maco Pharma S.A., where his expertise has been integral in driving innovative solutions in medical technology. In addition, he has collaborated with notable colleagues, including Thierry Verpoort and Maurice Behague, contributing to a robust exchange of ideas and advancements in their field.

Conclusion

Francis Goudaliez stands out as a significant figure in the realm of biomedicine, particularly in the innovation of platelet lysate treatments. His 18 patents underscore his commitment to advancing medical technologies that prioritize safety and efficacy, paving the way for more effective therapeutic solutions in the healthcare industry.

Profile summary based on public USPTO records.